Milan, Italy, March 2, 2017 – Newron Pharmaceuticals S.p.A. (“Newron”), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the
Milan, Italy and Morristown, NJ, USA, February 21, 2017 - Newron Pharmaceuticals S.p.A. (“Newron”), a biopharmaceutical company focused on the development of novel therapies for
Milan – January 10, 2017 – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with
Milan, Italy and Morristown, NJ, USA, January 3, 2017 – Newron Pharmaceuticals S.p.A. (“Newron”), a biopharmaceutical company focused on the development of novel therapies for
The information on the following pages may be made available in the United States. By clicking on the link below, you agree that you are in the United States.
